ALLOGENE THERAPEUTICS INC (ALLO:NASDAQ)
$3.34 0.62 (22.7941%)
Analysed ALLOGENE THERAPEUTICS INC (ALLO:NASDAQ) News Sources
Allogene Therapeutics Touts Early ALPHA3 Win: cema-cel MRD Clearance 58% vs 17%, No CRS/ICANS
13-04-2026
marketbeat.com
Natera Highlights Positive Interim Futility Analysis from Allogene Therapeutics’ MRD-Guided ALPHA3 Trial in Large B-Cell Lymphoma
13-04-2026
yahoo.com
Allogene Therapeutics Reports Interim Futility Analysis from Pivotal ALPHA3 Trial Showing 58.3% MRD Clearance with Cemacabtagene Ansegedleucel (Cema-Cel) vs. 16.7% in Observation Arm in First-Line Consolidation LBCL
13-04-2026
yahoo.com
Why Do Analysts See 180%+ Upside for Allogene Therapeutics (ALLO)?
12-04-2026
yahoo.com
Allogene Therapeutics to Announce Interim Futility Analysis Data from its Pivotal Phase 2 ALPHA3 Trial with Cemacabtagene Ansegedleucel (Cema-Cel) in First-Line Consolidation LBCL on Monday, April 13, 2026
10-04-2026
yahoo.com
Why Allogene Therapeutics (ALLO) Says Its Lead Cancer Program Is Still on Track in 2026
29-03-2026
yahoo.com
Piper Sandler Analysts Bullish on Allogene Therapeutics (ALLO) Ahead of Key ALPHA3 Data Readout
20-03-2026
yahoo.com
Allogene Therapeutics Posts Narrower-Than-Expected Loss in Q4
13-03-2026
yahoo.com
Allogene Therapeutics, Inc. Q4 2025 Earnings Call Summary
13-03-2026
moby.co
Allogene Therapeutics Inc (ALLO) Q4 2025 Earnings Call Highlights: Financial Stability and ...
13-03-2026
yahoo.com
What is the current price of ALLOGENE THERAPEUTICS INC (ALLO:NASDAQ)?
The current price of ALLOGENE THERAPEUTICS INC (ALLO:NASDAQ) is $3.34.
ALLOGENE THERAPEUTICS INC (ALLO:NASDAQ) absolute price change since previous trading day?
The absolute price change of ALLOGENE THERAPEUTICS INC (ALLO:NASDAQ) since the previous trading day is $0.62.
ALLOGENE THERAPEUTICS INC (ALLO:NASDAQ) percentage price change since previous trading day?
The percentage price change of ALLOGENE THERAPEUTICS INC (ALLO:NASDAQ) since the previous trading day is 22.7941%.
What is the most recent average sentiment score for ALLOGENE THERAPEUTICS INC (ALLO:NASDAQ)?
The most recent average sentiment score for ALLOGENE THERAPEUTICS INC (ALLO:NASDAQ) is 79 out of 100.
What is the most recent average sentiment for ALLOGENE THERAPEUTICS INC (ALLO:NASDAQ)?
The most recent sentiment for ALLOGENE THERAPEUTICS INC (ALLO:NASDAQ) is .
SEC-8K** Filing Available For ALLOGENE THERAPEUTICS INC (ALLO:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.